In vitro Services

In Vitro Preclinical Lab Services

Your Trusted Partner for In Vitro Preclinical Lab Services

BIOQUAL provides in vitro preclinical services spanning cell-based assays, immunoassays, viral testing, toxicity and cytotoxicity testing, and custom assay development.. With our extensive capabilities and dedication to high-quality, reproducible results, we help accelerate your research and provide crucial insights into efficacy, safety, and mechanism of action (MoA).

In Vitro Assay and Testing Services to Fit Your Needs

Don’t see the assay or model you need from the lists below?

Contact us to discuss your unique requirements—our team is committed to developing tailored solutions to meet your specific research goals.

Cell-Based Assays

Immunoassays

Toxicity and Cytotoxicity Testing

Viral Load Testing

Tailored Assay Development

Cell-Based Assays

PRNT and microneutralization assays quantify the ability of antibodies to neutralize viral infection in cell-based systems, supporting vaccine and therapeutic development programmes.

 

Our cell-based assays are essential tools for assessing the activity, efficacy, and potential toxicity of new compounds. By leveraging a variety of primary cells, stem cells, and engineered cell lines, BIOQUAL provides insights into cellular responses to therapeutics.

Apoptosis and Necrosis Assays

Evaluate pathways involved in cell death.

Proliferation and Viability Assays

Measure cell growth and cytotoxicity.

Immunoassays

BIOQUAL’s comprehensive immunoassay services measure protein levels, binding events, and immune responses. These assays are essential for analyzing target expression and validating biological responses.

ELISA

Measure the presence and concentration of antibodies, ligands, proteins or biomarkers.

Western Blot Analysis

Assess protein expression and post-translational modifications.

Flow Cytometry

Multiparametric fluorescence-based assays for characterization and analysis of single cells.

Hemagglutination Assay

Measure the amount of influenza virus in a sample by leveraging the influenza virus’s hemagglutinin (HA) protein, which causes red blood cells to agglutinate or stick together.

Hemagglutination Inhibition (HAI) Assays

Measure the presence and concentration of antibodies against influenza virus, thus providing an estimate of the level of immunity against the influenza virus.

Neuraminidase Inhibition (NAI) Assays

Assess the neuraminidase (NA) inhibiting antibody titers or activity of compounds in response to Influenza virus.

LUMINEX

Simultaneously measure multiple analytes, such as cytokines, chemokines, and biomarkers, in a single sample.

Plaque Reduction Neutralization Tests (PRNT) and Microneutralization (MN) Assays

Quantify the ability of antibodies to block viral infection in cell-based systems.

Enzyme-linked ImmunoSpot (ELISpot) assay

Measure the frequency of cytokine-secreting cells at the single-cell level.

Toxicity and Cytotoxicity Testing

We provide in vitro toxicology and cytotoxicity testing to detect potential adverse effects early in the development process, helping to establish potential safety profiles.

MTT Assays

Assess cell viability and mitochondrial function.

Viral Load Testing

We provide precise quantification of viral particles, infectivity, and nucleic acid levels to support vaccine development, antiviral studies, and pathogen detection.

Plaque Assays

Measure infectious virus particles in samples.

Tissue Culture Infectious Dose 50 (TCID50) Assay

Quantify the viral dose required to infect 50% of cell cultures, supporting studies on viral infectivity, vaccine potency, and antiviral development.

RT-PCR Pathogen Detection

Measure target viral nucleic acid in sample.

Tailored Assay Development

BIOQUAL recognizes the uniqueness of every project. Our team collaborates with clients to develop customized assays that align with specific therapeutic goals and research targets. We prioritize flexibility and precision, ensuring that each assay is optimized for your needs.

Advanced Laboratory Capabilities

BIOQUAL’s laboratories are designed to meet the highest safety and quality standards:

Biosafety Levels and Facilities


Our labs operate up to Select Agent/BSL-3 standards, ensuring the safe handling of highly infectious agents.

State-of-the-Art Technology

From immunoassays to advanced imaging, BIOQUAL’s technology stack supports complex research needs with precision.

Quality and Compliance

We are AAALAC-accredited and can run regulatory-compliant experiments for high-stakes preclinical studies and IND submissions.

Contact Us
Today!

Learn more about our services and how they can support your research. Reach out to us for a consultation and get started.